New Key Statistics Module, Z-Score and F-Score
NAS:NKTR Key Ratios
| Market Cap $ M | 219.05 |
| Enterprise Value $ M | 70.96 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.77 |
| Price/Sales | 2.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 93.00 |
| EPS (TTM) $ | -0.90 |
| Beneish M-Score | 5.68 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.47 |
| EV-to-EBITDA | -0.49 |
| PEG | -- |
| Shares Outstanding M | 184.08 |
| Net Margin (%) | -190.09 |
| Operating Margin % | -145.03 |
| Pre-tax Margin (%) | -190.17 |
| Quick Ratio | 4.90 |
| Current Ratio | 5.15 |
| ROA % (ttm) | -42.69 |
| ROE % (ttm) | -127.63 |
| ROIC % (ttm) | -157.07 |
| Dividend Yield % | -- |
| Altman Z-Score | -14.38 |
NKTR Number of Guru Trades
NKTR Volume of Guru Trades
Gurus Latest Trades with NAS:NKTR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NKTR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nektar Therapeutics Insider Transactions
No Available Data
News about NAS:NKTR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers